Fny Investment Advisers, LLC United Therapeutics Corp Transaction History

Fny Investment Advisers, LLC

  • $194 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 10, 2022
SELL
$184.32 - $216.08 $92,160 - $108,040
-500 Closed
0 $0
Q3 2021

Oct 13, 2021
BUY
$179.86 - $214.88 $89,930 - $107,440
500 New
500 $92,000
Q2 2021

Jul 14, 2021
SELL
$170.47 - $211.93 $66,824 - $83,076
-392 Closed
0 $0
Q1 2021

Apr 12, 2021
BUY
$153.94 - $174.85 $60,344 - $68,541
392 New
392 $65,000

Others Institutions Holding UTHR

# of Institutions
681
Shares Held
42.2M
Call Options Held
194K
Put Options Held
298K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email